DEXTENZA ® is a registered trademark of Ocular Therapeutix, Inc. The Ocular Therapeutix logo, AXPAXLI™, ELUTYX™, and Ocular Therapeutix™ are trademarks of Ocular Therapeutix, Inc.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Investigators find only moderate agreement between ocular POCUS and ophthalmologist diagnoses in emergency settings for vision-threatening conditions.

Investigators call for stricter eye protection mandates and school awareness programs to reduce the global burden of ophthalmic trauma.

Ocular Therapeutix (OCUL) has been drawing attention after recent share price swings, including a 6.8% decline over the past day, offset by a 14.9% gain over the past week. Against this backdrop, the ...

Shares of ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) fell 8.6% in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about ...

Learn more about whether Ocular Therapeutix, Inc. or Phibro Animal Health Corporation is a better investment based on AAII's ...

We recently published 10 Stocks Standing Tall Amid Market Fall; 6 Hit Record Highs. Ocular Therapeutix, Inc. (NASDAQ:OCUL) is one of the best performers on Monday. Ocular Therapeutix surged to a new ...

Good morning, and welcome to the Ocular Therapeutix Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded and will be available for ...